A
Amnon Rosenthal
Researcher at Boston Children's Hospital
Publications - 140
Citations - 6265
Amnon Rosenthal is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Heart disease & Cardiac catheterization. The author has an hindex of 48, co-authored 140 publications receiving 6154 citations. Previous affiliations of Amnon Rosenthal include Harvard University & University of Amsterdam.
Papers
More filters
Journal ArticleDOI
Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
Richard D. Propper,Richard D. Propper,Barry J. Cooper,Barry J. Cooper,Robert R. Rufo,Robert R. Rufo,Arthur W. Nienhuis,Arthur W. Nienhuis,W. French Anderson,W. French Anderson,H. Franklin Bunn,H. Franklin Bunn,Amnon Rosenthal,David G. Nathan,David G. Nathan +14 more
TL;DR: Constant subcutaneous deferoxamine administration may prove to be an effective and practical means of eliminating large quantities of iron in siderosis.
Journal ArticleDOI
A forty-year review of bacterial endocarditis in infancy and childhood.
TL;DR: A retrospective review of 149 episodes of bacterial endocarditis in 141 patients under 25 years of age at The Children's Hospital Medical Center from 1933 through June of 1972 demonstrates increasing survival and a distinct change in the frequency of underlying congenital heart disease and rheumatic heart disease.
Journal ArticleDOI
Interrupted aortic arch: Surgical treatment
Richard Van Praagh,Richard Van Praagh,William F. Bernhard,William F. Bernhard,Amnon Rosenthal,Amnon Rosenthal,Lucy Parisi,Lucy Parisi,Donald C. Fyler,Donald C. Fyler +9 more
TL;DR: A new palliative surgical procedure for interruption of the aortic arch was successfully performed in an infant, and may prove life-saving in the hypoplastic left heart syndrome, with the addition of atrial septal defect creation when left atrial decompression is indicated.
Journal ArticleDOI
Extracardiac Abnormalities in Infants With Congenital Heart Disease
TL;DR: Extracardiac anomalies (ECA) occur in 25% of infants seen during the first year of life for significant cardiac disease and significantly increases the mortality in infants with CHD.
Journal ArticleDOI
Improving results with first-stage palliation for hypoplastic left heart syndrome
Mark D. Iannettoni,Edward L. Bove,Ralph S. Mosca,Flavian M. Lupinetti,Parvin C. Dorostkar,Achi Ludomirsky,Dennis C. Crowley,Thomas J. Kulik,Amnon Rosenthal +8 more
TL;DR: Results indicate that survival for patients after first-stage reconstruction for hypoplastic left heart syndrome has significantly improved in recent years, and older age was a strong risk factor, with a hospital survival of 91% for those patients undergoing first- stage palliation within the first month of life.